Benefit versus risk of chromosomal microarray analysis performed in pregnancies with normal and positive prenatal screening results: A retrospective study

BACKGROUND: Most studies on chromosomal microarray analysis (CMA) and amniocentesis risks have not evaluated pregnancies with low risk for genetic diseases; therefore, the efficacy and safety of CMA and amniocentesis in this population are unclear. This study aimed to examine the benefits and risks...

Descripción completa

Detalles Bibliográficos
Autores principales: Moshonov, Rami, Hod, Keren, Azaria, Bella, Abadi-Korek, Ifat, Berger, Rachel, Shohat, Mordechai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075189/
https://www.ncbi.nlm.nih.gov/pubmed/33901244
http://dx.doi.org/10.1371/journal.pone.0250734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075189/
https://www.ncbi.nlm.nih.gov/pubmed/33901244
http://dx.doi.org/10.1371/journal.pone.0250734

Ejemplares similares